Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 17Plasma cell 15Other hematologic neoplasm 12Breast 6Dermatologic 5Myeloid 4Genitourinary 4CNS 3Endocrine 2Sarcoma 1NET 1Head & Neck 1Gastrointestinal 1

Conditions

Glioma 2Diffuse Intrinsic Pontine Glioma 2

Interventions

Temozolomide 171Bevacizumab 106Radiotherapy 87Radiation 38Cyclophosphamide 38Etoposide 34Carboplatin 34Magnetic Resonance Spectroscopy 32Irinotecan 32Radiosurgery 27Vincristine 25pembrolizumab 24Everolimus 23Cisplatin 23Nivolumab 22Radiotherapy, Intensity-Modulated 19Isotretinoin 19Filgrastim 19Erlotinib Hydrochloride 19Topotecan 18Lomustine 17Vorinostat 16Doxorubicin 16Granulocyte Colony-Stimulating Factor 15sargramostim 14antineoplaston A10 13Radiotherapy, Conformal 13antineoplaston AS 2-1 12Granulocyte-Macrophage Colony-Stimulating Factor 12dinutuximab 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Panobinostat × CNS × Clear all
NCT04804709 2025-06-08

Non-Invasive Focused Ultrasound (FUS) With Oral Panobinostat in Children With Progressive Diffuse Midline Glioma (DMG)

Columbia University

Phase 1 Terminated
5 enrolled 11 charts
CNS

Diffuse Intrinsic Pontine Glioma

NCT02717455 2024-04-25

PBTC-047

Pediatric Brain Tumor Consortium

Phase 1 Completed
53 enrolled 25 charts
CNS

Diffuse Intrinsic Pontine Glioma, Glioma

NCT00859222 2017-03-14

LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma

Dana-Farber Cancer Institute

Phase 1/2 Completed
51 enrolled 18 charts
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡